Circulating miRNA panels for specific and early detection in bladder cancer
Wataru Usuba(St. Marianna University School of Medicine), Takahiro Ochiya(Unknown), Hiroyuki Fujimoto(Tokyo National Hospital), Yusuke Yamamoto(Ehime University), Tatsuya Chikaraishi(St. Marianna University School of Medicine), Shumpei Niida(National Center for Geriatrics and Gerontology), Ken Kato(National Cancer Center Hospital East), Satoko Takizawa(Toray Industries, Inc. (Japan)), Hideo Sasaki(Yamagata University), Shin Egawa, Yoshiaki Aoki(Dynavax Technologies (Germany)), Juntaro Matsuzaki(Keio University), Makiko Ichikawa(Toray Industries, Inc. (Japan)), Fumihiko Urabe(Jikei University School of Medicine)
Cited by 282
Related Papers
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis
|Journal of Biological Chemistry|2013|770
Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier
|Nature Communications|2015|706
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen
|Nature Communications|2014|595